中信证券股份有限公司 关于上海艾为电子技术股份有限公司归还募集资金及 继续使用部分闲置募集资金暂时补充流动资金的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为上海 艾为电子技术股份有限公司（以下简称"艾为电子"、"公司"）首次公开发 行股票并在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》《科创板上市公司持续监管办法（试 行）》及《上市公司募集资金监管规则》等法律法规的有关规定，对艾为电子 继续使用部分闲置募集资金暂时补充流动资金事项进行了专项核查，并出具本 核查意见。核查情况如下： 一、募集资金基本情况 为规范公司募集资金管理和使用，保护投资者权益，公司设立了相关募集资 金专项账户。募集资金到账后，已全部存放于经公司董事会批准开设的募集资金 专项账户内，公司已与保荐人、存放募集资金的商业银行签署了募集资金三方监 管协议和募集资金四方监管协议。 二、前次用于暂时补充流动资金的募集资金归还情况 会议，审议通过了《关于公司继续使用部分闲置募集资金暂时补充流动资金的议 -1- 案》，同意公司继续使用不超过人民币 60,000 万元（含本数）的闲 ...

有研半导体硅材料股份公司 募集资金管理制度 第一章 总 则 第一条 为规范有研半导体硅材料股份公司（以下简称"公司"）募集资金管 理，提高募集资金使用效率，保障投资者的合法权益，根据《中华人民共和国公 司法》 （以下简称" 《公司法》"） 《中华人民共和国证券法》 （以下简称" 《证券法》"） 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上市公 司募集资金监管规则》等，制定本制度。 第二条 本制度所称募集资金系指公司通过发行股票或者其他具有股权性质 的证券，向投资者募集并用于特定用途的资金，但不包括公司实施股权激励计划 募集的资金。 第三条 公司建立健全募集资金管理制度，及时披露募集资金的使用情况， 并确保本制度的有效实施。公司募集资金应当专款专用，应当符合国家产业政策 和相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于主营业 务，有利于增强公司竞争能力和创新能力。募集资金不得用于持有财务性投资， 不得直接或者间接投资于以买卖有价证券为主要业务的公司。 公司募集资金应当投资于科技创新领域，促进新质生产力发展。 法律、法规及中国证监会的监管规则对公司发行股份、可转换公司债券 ...

证券代码：600531 证券简称：豫光金铅 债券代码：110096 债券简称：豫光转债 河南豫光金铅股份有限公司 关于前次募集资金使用情况的专项报告 根据中国证监会发布的《上市公司监管指引第 2 号——上市公司募集资金管 理和使用的监管要求》和上海证券交易所发布的《上海证券交易所上市公司自律 监管指引第 1 号——规范运作》等有关规定，河南豫光金铅股份有限公司（以下 简称"公司"或"本公司"）董事会编制了截至 2025 年 6 月 30 日止的《河南豫 光金铅股份有限公司关于前次募集资金使用情况的专项报告》。 一、前次募集资金基本情况 （一）前次募集资金情况 经中国证券监督管理委员会《关于同意河南豫光金铅股份有限公司向不特定 对象发行可转换公司债券注册的批复》（证监许可〔2024〕887 号）核准，公司 于 2024 年 8 月 12 日向不特定对象发行面值总额 71,000 万元可转换公司债券， 期限 6 年，每张面值为人民币 100 元，发行数量 710.00 万张，募集资金总额为 人民币 710,000,000.00 元。扣除发行费用人民币 13,677,575.47 元（不含税）后， 募集资金净额为人 ...

Core Points - The company has raised a total of RMB 1,854.59 million through its initial public offering, with a net amount of RMB 1,663.97 million after deducting issuance costs [1] - As of June 30, 2025, the company has utilized RMB 1,000.56 million of the raised funds, leaving a balance of RMB 635.77 million [1][4] - The company has established a management system for the raised funds to ensure compliance with relevant regulations and protect investor interests [1] Fundraising Overview - The company issued 187.14 million shares at a price of RMB 9.91 per share, resulting in total fundraising of RMB 1,854.59 million [1] - After deducting issuance costs, the actual net amount raised was RMB 1,663.97 million [1] - The company has cumulatively used RMB 1,000.56 million from the raised funds in previous years [1] Fund Utilization - In the current year, the company has used RMB 81.41 million of the raised funds [4] - The remaining balance of the raised funds as of June 30, 2025, is RMB 635.77 million [1][4] - The company has not engaged in any temporary use of idle funds to supplement working capital during the reporting period [2][4] Fund Management - The company has signed tripartite and quadripartite agreements with its sponsor and banks to regulate the storage and management of the raised funds [1] - The company has implemented a cash management strategy for idle funds, allowing for investment in low-risk financial products [3] - The total amount of idle funds used for cash management is capped at RMB 800 million [3] Project Status - The company has not made any changes to the fundraising investment projects during the reporting period [4] - There have been no instances of early investment or replacement of fundraising projects [4] - The company has reported that the progress of certain projects has been delayed due to market demand fluctuations and other objective factors [4]

正和生态公告，公司已将董事会审议通过之日起使用的暂时补充流动资金的募集资金2000万元全部归还 至募集资金专用账户。其中，暂时补充流动资金600万元(从尾号6898账户转出)，由于6898账户目前处 于冻结状态，本次归还至尾号为7641的募集资金专户(与6898账户同为募投项目"生态保护与环境治理研 发能力提升项目"的募集资金专户)。同时，公司已将上述归还情况及时通知了公司保荐机构和保荐代表 人。 ...

苏州宝丽迪材料科技股份有限公司 第一章 总则 第三条 公司募集资金应当专款专用。公司使用募集资金应当符合国家产业 政策和相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于主 营业务，有利于增强公司竞争能力和创新能力。中国证监会对公司发行股份、可 转换公司债券购买资产并募集配套资金用途另有规定的，从其规定。 第四条 公司董事会应当持续关注募集资金存放、管理和使用情况，有效防 范投资风险，提高募集资金使用效益。 公司的董事、高级管理人员应当勤勉尽责，确保公司募集资金安全，不得操 控公司擅自或变相改变募集资金用途。 第五条 公司应当真实、准确、完整地披露募集资金的实际使用情况，出现 严重影响募集资金投资计划正常进行的情形时，应当及时公告。 募集资金投资项目通过公司的子公司或者公司控制的其他企业实施的，公司 应当确保该子公司或者受控制的其他企业遵守本制度规定。 第一条 为了加强对苏州宝丽迪材料科技股份有限公司（以下简称"公司"） 募集资金的监管，提高募集资金使用效率，根据《中华人民共和国公司法》《中 华人民共和国证券法》《上市公司证券发行注册管理办法》《上市公司募集资金 监管规则》 《深圳证券交易所创业板 ...

证券代码：300785 证券简称：值得买 公告编号：2025-034 北京值得买科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意北京值得买科技股份有限公司向特 定对象发行股票注册的批复》（证监许可[2020]2780 号），北京值得买科技股份 有限公司（以下简称"公司"）获准向特定对象发行人民币普通股 8,196,437 股， 每股发行价人民币 88.88 元，募集资金总额人民币 728,499,320.56 元。 截至 2020 年 12 月 3 日止，本次向特定对象发行股票（以下简称"再融资"）实际收到募 集资金总额人民币 714,678,578.66 元（已扣除不含税承销与保荐费），扣除审 计及验资费、律师费、其他费用等发行费用 1,618,744.65 元（不含税）后，实 际 募 集 资 金 净 额 为 人民 币 713,059,834.01 元 ， 其 中 新 增 注 册 资 本 人 民 币 月 3 日到位，经中审众环会计师事务所（特殊普通合伙）审验确认并出具《北京 值得买科 ...

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the usage of raised funds by Guangzhou Jitai Chemical Co., Ltd. It outlines the amounts raised, the specific projects funded, and the management of these funds, ensuring compliance with regulatory requirements. Group 1: Fundraising Overview - The company raised a total of RMB 299,999,988.75 from a non-public offering of A-shares in 2020, with a net amount of RMB 280,999,988.75 after deducting underwriting fees [1][2] - In 2022, the company raised RMB 169,602,361.50 from a targeted issuance of A-shares, with a net amount of RMB 153,436,236.32 after fees [3][4] Group 2: Fund Usage and Balances - As of June 30, 2025, the company had used RMB 272,944,538.92 from the 2020 fundraising, with a remaining balance of RMB 7,449,565.95 [5][6] - For the 2022 fundraising, RMB 153,440,976.79 was utilized, leaving a balance of RMB 81,110.48 as of June 30, 2025 [7][8] Group 3: Fund Management and Compliance - The company has established a fund management system in accordance with relevant laws and regulations, ensuring that funds are stored in dedicated accounts and used for specified projects [9][10] - The company has signed tripartite and quadripartite supervision agreements with banks and underwriters to ensure compliance with fundraising regulations [11][12] Group 4: Project Adjustments and Changes - The company adjusted its project plans based on operational needs and market conditions, including changes to production capacities and project timelines [15][16][17] - The total investment for the adjusted projects was revised from RMB 42,025.89 million to RMB 39,831.01 million, with completion dates extended [17] Group 5: Remaining Funds and Future Plans - As of June 30, 2025, the company has unutilized funds of RMB 744,960.00 from the 2020 fundraising and RMB 81,110.48 from the 2022 fundraising, all stored in dedicated accounts [19][20] - The company plans to use the remaining funds for project completion and operational needs, ensuring efficient use of resources [21][22]

Summary of Key Points Core Viewpoint The announcement provides a detailed report on the fundraising activities and the usage of raised funds by Huarong Chemical Co., Ltd. for the first half of 2025, ensuring compliance with regulatory requirements and outlining the company's financial management practices. Fundraising Overview - The company raised a total of RMB 966 million through the issuance of 12 million shares at RMB 8.05 per share, with a net amount of RMB 901.42 million after deducting issuance costs [1]. - The company has a total of RMB 406.42 million in excess funds raised [1]. Fund Usage - In the first half of 2025, the company utilized RMB 303,800 for investment projects and earned net interest income and cash management returns of RMB 4.5773 million [2]. - As of June 30, 2025, the cumulative investment in projects amounted to RMB 123.41 million, with a remaining balance of RMB 397.52 million [2]. Fund Management - The company has established a management system for the raised funds, ensuring they are stored in dedicated accounts and used according to regulatory guidelines [2][3]. - A tripartite supervision agreement was signed with several banks to oversee the management and usage of the raised funds [3]. Fund Storage Status - As of June 30, 2025, three dedicated accounts for the raised funds have been closed after the completion of related projects [5]. - The company has adhered to the tripartite supervision agreements without any violations [4]. Financial Reporting - The company reported a net profit of RMB 32.88 million for the first half of 2025, with a proposed cash dividend of RMB 0.40 per share, totaling RMB 19.2 million [43][45]. - The company has made changes to its accounting estimates to better reflect its financial situation, particularly regarding expected credit losses on receivables [48][49]. Board and Supervisory Meetings - The board and supervisory meetings held on August 12, 2025, approved the half-year report and the profit distribution plan, with unanimous votes [17][36].

Core Viewpoint - The company has released its 2025 semi-annual report, which reflects its financial status and operational results, ensuring compliance with relevant regulations and standards [3][17][37]. Group 1: Company Overview - The company is Zhejiang Zhenray Technology Co., Ltd., with stock code 688270 and is listed on the Shanghai Stock Exchange [3][14]. - The company has confirmed that there are no significant risks affecting its production and operations during the reporting period [1][3]. Group 2: Financial Data - The company reported a total asset impairment provision of 23,675,673.34 yuan for the first half of 2025, which includes credit impairment losses of 14,597,903.01 yuan and inventory impairment losses of 9,077,770.33 yuan [29][30][31]. - The actual use of raised funds in the first half of 2025 amounted to 149,507,600 yuan, with a remaining balance of 136,065,800 yuan as of June 30, 2025 [37][39]. Group 3: Board and Supervisory Committee Decisions - The board and supervisory committee have approved the semi-annual report and its summary, confirming that the information disclosed is true, accurate, and complete [6][17][35]. - The board has also approved the adjustment of the share repurchase price limit from 38.13 yuan to 74 yuan per share to ensure the smooth implementation of the repurchase plan [47][54]. Group 4: Fund Management - The company has established a management system for raised funds, ensuring compliance with regulations and safeguarding investor interests [37][39]. - As of June 30, 2025, the company has not used idle raised funds to temporarily supplement working capital [40]. Group 5: Share Repurchase Plan - The company has conducted share repurchases, acquiring a total of 189,431 shares, which is 0.0885% of the total share capital, with a total expenditure of 6,254,681 yuan [51][52]. - The adjustment of the repurchase price limit is deemed necessary to maintain the company's value and protect shareholder interests [54][56].